Vaccines and Related Biological Products Advisory Committee
May 6, 2004 Meeting
Date and Time:
The meeting will be held via teleconference on May 6, 2004; 1:30 p.m to 3:30 p.m.
Location:
NIH Campus, Food and Drug Administration, Building 29B, Conference Room C, 8800 Rockville Pike, Bethesda, MD. This meeting will be held by teleconference. The public is welcome to attend the meeting at the above location. A speaker phone will be provided at the specified location for public participation in this meeting. Important information about transportation and directions to the NIH campus, parking, and security procedures is available on the internet at http://www.nih.gov/about/. Click on the Visitor Information icon on the left side of the screen. Visitors must show two forms of identification such as a Federal employee badge, driver's license, passport, green card, etc.
Contact Persons:
Christine Walsh, R.N., or Denise Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting.
Agenda:
The committee will hear an overview on the Laboratory of DNA Viruses, Division of Viral Products, Office of Vaccines Research and Review. In closed session, the committee will discuss the report from the Laboratory Site Visit on March 4, 2004.
Oral Presentations:
Between approximately 2:00 and 3:00 p.m. oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before April 30, 2004.
Closed Committee Deliberations:
From 3:00 to 3:30 p.m. the meeting will be closed to permit discussion where disclosure would constitute a clearly unwarranted invasion of personal privacy (5 U.S.C. 552b(c)(6)). The committee will discuss a review of internal research programs in the Office of Vaccines Research and Review, Division of Viral Products.
|
